跳至主要内容
临床试验/NL-OMON28113
NL-OMON28113招募中不适用

Prospective multicenter cohort for evaluation of changes in Immune profile and platelet function after start of TPO-receptor agonist in patients with ITP

MC Utrecht0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age 16 years and older
  • - Previously confirmed diagnosis of primary ITP with current platelet counts of <100x109/L
  • - Will start treatment with eltrombopag
  • - Willing and be able to understand the study information and sign the informed consent form.

排除标准

  • - Documented history of persisting severe anemia (defined as hemoglobin <6.0 mmol/L for men and women)
  • - Treatment with rituximab in the past 9 months
  • - Treatment with any immune modulating drug other than corticosteroids in the past 3 months

研究者

发起方
MC Utrecht

相似试验